Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Turing Pharmaceuticals AG
DescriptionUndisclosed oral compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEpilepsy
Indication DetailsTreat epileptic encephalopathies
Regulatory Designation U.S. - Fast Track (Treat epileptic encephalopathies)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today